Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'cardiovascular' OR with Authors including 'cardiovascular' OR with Abstract including 'cardiovascular' OR with Keywords including 'cardiovascular'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Graham JDP, Khalidi AI The actions of d-lysergic acid diethylamide (L.S.D. 25). Part 1. Gene... J. Fac. Med. Iraq. 1954
Graham JDP, Khalidi AI The actions of d-lysergic acid diethylamide (L.S.D. 25).Part 2. Centra... J. Fac. Med. Iraq 1954
Salmoiraghi GC, McCubbin ... Effects of d-lysergic acid diethylamide and its brom derivative on car... J. Pharmacol. Exper.... 1957
Lecomte J, Fischer P 5-Hydroxytryptamine et choc anaphylactique du lapin. Arch. internat. phys... 1958
Dobkin AB, Harland JH Drugs which stimulate affective behavior. I. Action of lysergic acid ... Anesthesia 1960
Gonzales EA Balourdas TA Lysergic acid diethylamide (LSD25)'s effects on the microcirculation Pharmacologist 1967
Vick JA Cardiovascular effects of guanazole (NSC 1895) Proc. Amer. Ass. Can... 1969
Mandell AJ, Morgan M Indoleethylamine N-methyltransferase in human brain Nat New Biol 1971
Kay DC, Martin WR, Crough... EEG and cardiovascular effects of tryptamine and LSD in the encephale ... Pharmacologist 1973
Cheng HC, Long JP, Barfkn... Cardiovascular effects of 2, 5-dimethoxy-4-methylamphetamine DOM, STP J Pharmacol Exp Ther 1973
Bye C, Munro-Faure AD, Pe... A comparison of the effects of 1-benzylpiperazine and dexamphetamine o... Eur J Clin Pharmacol 1973
Nichols DE, Ilhan M, Long... Comparison of Cardiovascular, Hyperthermic, and Toxic Effects of Para-... Arch Int de Pharmaco... 1975
Friedman E, Lambert GA, B... 2,5-Dimethoxy-4-methylamphetamine (DOM)- a central component of its ca... Eur J Pharmacol 1978
Marquardt GM, DiStefano V... Pharmacological and Toxicological Effects of B-3,4-Methylenedioxyamphe... Toxicol.Appl.Pharmac... 1978
Hunt CA, Jones RT Tolerance and disposition of tetrahydrocannabinol in man J Pharmacol Exp Ther 1980
Downing J The psychological and physiological effects of MDMA on normal voluntee... J Psychoactive Drugs 1986
Davis WM, Catravas JD, Wa... Effects of an i.v. lethal dose of 3,4-methylenedioxyamphetamine (MDA) ... Gen Pharmacol 1986
Battaglia G, De Souza EB Pharmacologic profile of amphetamine derivatives at various brain reco... NIDA Res Monogr 1989
Herkenham M, Lynn AB, Lit... Cannabinoid receptor localization in brain Proc Natl Acad Sci U... 1990
Chadwick IS, Curry PD, Li... Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associat... J R Soc Med 1991
Dedeo?lu A, Fisher LA Central and peripheral injections of the 5-HT2 agonist, 1-2,5-dimethox... J Pharmacol Exp Ther 1991
Bedford Russell AR, Schwa... Accidental ingestion of 'Ecstasy' (3,4-methylenedioxymethylamphetamine... Arch Dis Child 1992
Gouzoulis E, von Bardeleb... Neuroendocrine and cardiovascular effects of MDE in healthy volunteers Neuropsychopharmacol... 1993
Erspamer V, Erspamer GF, ... Pharmacological studies of 'sapo' from the frog Phyllomedusa bicolor s... Toxicon 1993
Strassman RJ, Qualls CR Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendoc... Arch Gen Psychiatry 1994
Fitzgerald JL, Reid JJ Sympathomimetic Actions of Methylenedioxymethamphetamine in Rat and Ra... J Pharm Pharmacol 1994
Hanyu S, Ikeguchi K, Imai... Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ... Eur Neurol 1995
Benjamin J, Greenberg BD,... Daily administration of m-chlorophenylpiperazine to healthy human volu... Psychopharmacology B... 1996
Vollenweider FX, Gamma A,... Psychological and cardiovascular effects and short-term sequelae of MD... Neuropsychopharmacol... 1998
Brody S, Krause C, Veit R... Cardiovascular autonomic dysregulation in users of MDMA ('Ecstasy') Psychopharmacology (... 1998
Mas M, Farre M, de la Tor... Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4... J Pharmacol Exp Ther 1999
McElhatton PR, Bateman DN... Congenital anomalies after prenatal ecstasy exposure Lancet 1999
Ghuran A, Nolan J Recreational drug misuse: issues for the cardiologist Heart 2000
O'Cain PA, Hletko SB, Ogd... Cardiovascular and Sympathetic Responses and Reflex Changes Elicited b... Physiology 2000
Liechti ME, Vollenweider ... Acute psychological and physiological effects of MDMA ('Ecstasy') afte... Eur Neuropsychopharm... 2000
Rothman RB, Partilla JS, ... Neurochemical neutralization of methamphetamine with high-affinity non... Synapse 2000
Liechti ME, Vollenweider ... The serotonin uptake inhibitor citalopram reduces acute cardiovascular... J Psychopharmacol 2000
Lester SJ, Baggott M, Wel... Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine. A Double-... Ann Intern Med 2000
Pedersen NP, Blessing WW Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-... J Neurosci 2001
Riba J, Rodri­guez-Fornel... Subjective effects and tolerability of the South American psychoactive... Psychopharmacology (... 2001
Pedersen NP, Blessing WW Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-... Journal of Neuroscie... 2001
Liechti ME, Vollenweider ... Which neuroreceptors mediate the subjective effects of MDMA in humans?... Hum Psychopharmacol ... 2001
Cannon DM, Keenan AK, Gui... In vitro neuronal and vascular responses to 5-HT in rats chronically e... Br J Pharmacol 2001
Macleod J, Davey Smith G,... Psychological stress and cardiovascular disease: empirical demonstrati... BMJ 2002
Stuerenburg HJ, Petersen ... Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and... Neuroendocrinol Lett 2002
Smith KM, Larive LL, Roma... Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hyd... Am J Health Syst Pha... 2002
Badon LA, Hicks A, Lord K... Changes in Cardiovascular Responsiveness and Cardiotoxicity Elicited d... J Pharmacol Exp Ther 2002
Sidney S Cardiovascular consequences of marijuana use J Clin Pharmacol 2002
Greene SL, Dargan PI, O'C... Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy") Am J Emerg Med 2003
Riba J, Valle M, Urbano G... Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects... J Pharmacol Exp Ther 2003
Frishman WH, Del Vecchio ... Cardiovascular manifestations of substance abuse: part 2: alcohol, amp... Heart Dis 2003
Hasler F , Grimberg U, Be... Acute psychological and physiological effects of psilocybin in healthy... Psychopharmacology 2004
Kaye J, Buchanan F, Kendr... Acute carbon dioxide exposure in healthy adults: evaluation of a novel... J Neuroendocrinol 2004
de la Torre R, Farre M, R... Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposit... Ther Drug Monit 2004
Egred M, Davis GK Cocaine and the heart Postgrad Med J 2005
Borlaug BA, Melenovsky V,... Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility i... Circulation 2005
Ding EL, Hutfless SM, Din... Chocolate and prevention of cardiovascular disease: a systematic revie... Nutr Metab (Lond) 2006
Haney M Opioid Antagonism of Cannabinoid Effects: Differences between Marijuan... Neuropsychopharmacol... 2007
Lile JA, Kendall SL, Baba... Evaluation of estradiol administration on the discriminative-stimulus ... Pharmacol Biochem Be... 2007
Nef HM, Moellmann H, Hilp... Apical regional wall motion abnormalities reminiscent to Tako-Tsubo ca... Int J Cardiol 2008
Burri A, Heinrichs M, Sch... The acute effects of intranasal oxytocin administration on endocrine a... Psychoneuroendocrino... 2008
Huang YC, Jeng CM, Cheng ... Ketamine-Associated Ulcerative Cystitis Tzu Chi Med J 2008
Tsai JH, Tsai KB, Jang MY Ulcerative cystitis associated with ketamine Am J Addict 2008
Farah R, Farah R Ecstasy (3,4-methylenedioxymethamphetamine)-induced inappropriate anti... Pediatr Emerg Care 2008
Lidder S, Dargan P, Sexto... Cardiovascular toxicity associated with recreational use of diphenylpr... J Med Toxicol 2008
Izzo AA, Borrelli F, Capa... Non-psychotropic plant cannabinoids: new therapeutic opportunities fro... Trends Pharmacol Sci 2009
Regan L, Mitchelson M, Ma... Mephedrone toxicity in a Scottish emergency department Emerg Med J 2010
Durham M Ivory wave: the next mephedrone? Emerg Med J 2011
Editors Emergency department visits after use of a drug sold as 'bath salts'--... MMWR Morb Mortal Wkl... 2011
Kremer C, Paulke A, Wunde... Variable adverse effects in subjects after ingestion of equal doses of... Forensic Sci Int 2011
Spiller HA, Ryan ML, West... Clinical experience with and analytical confirmation of 'bath salts' a... Clin Toxicol (Phila) 2011
Coppola M, Mondola R 3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and tox... Toxicol Lett 2011
Adebamiro A, Perazella MA Recurrent Acute Kidney Injury Following Bath Salts Intoxication Am J Kidney Dis 2011
Baumann MH, Partilla JS, ... Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV)... Neuropsychopharmacol... 2013
Kirkpatrick MG, Lee R, Wa... Effects of MDMA and Intranasal Oxytocin on Social and Emotional Proces... Neuropsychopharmacol... 2014
Hartung B, Kauferstein S,... Sudden unexpected death under acute influence of cannabis Forensic Science Int... 2014
Gonzalez D, Torrens M, Fa... Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions BioMed Research Inte... 2015
Litjens RP, Brunt TM How toxic is ibogaine? Clin Toxicol (Phila) 2016
Carbonaro TM, Gatch MB Neuropharmacology of N,N-dimethyltryptamine Brain Res Bull 2016
Batisse A, Peyrière H, Ei... [Use of psychostimulants in a sexual context: Analysis of cases report... Therapie 2016
Xi-Ping Huang, Che T, Man... Pharmacology OF W-18 AND W-15 bioRxiv 2016
Bershad AK, Weafer JJ, Ki... Oxytocin receptor gene variation predicts subjective responses to MDMA Soc Neurosci 2016
Assi S, Gulyamova N, Knel... The effects and toxicity of cathinones from the users' perspectives: A... Hum Psychopharmacol 2017
Nichols DE, Grob CS Is LSD Toxic? Forensic Science Int... 2018
Schifano F, Chiappini S Is there such a thing as a 'lope' dope? Analysis of loperamide-related... PLoS One 2018
Rickli A, Kolaczynska K, ... Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-D... Neurotoxicology 2019
Bershad AK, Schepers ST, ... Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid... Biol Psychiatry 2019
Berar A, Allain JS, Allar... Intoxication with 3-MeO-PCP alone: A case report and literature review Medicine (Baltimore) 2019